EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

A new bleeding risk score specifically developed for direct oral anticoagulants in a geriatric population

Matthieu Piccoli iD, George Pisica-Donose, Abdelhakim Hacil, Galdric Orvoën, Jean Philippe David, Judith Charbit, Rafaëlle Roth, Yara Antakly, Nicolas Boulloche, Ulric Vinsonneau, Stéphane Bouée, Pierre Krolak-Salmon und 11 weitere

Age and Ageing · 31.05.2025 · 54 (6)

DOI: 10.1093/ageing/afaf118 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Age and Ageing, online erschienen am 02.06.2025. Verfasst von Matthieu Piccoli und 22 weiteren Autor:innen. Beteiligte Einrichtung: APHP, Centre Université Paris Cité - Geriatrics Department, 54-56 rue PASCAL, Paris 75013, France. Hauptthemen laut MEDLINE: Hemorrhage, Atrial Fibrillation, Rivaroxaban, Factor Xa Inhibitors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although the use of direct oral anticoagulants increases in parallel with the increase in atrial fibrillation (AF) with age, none of the bleeding risk scores (HAS-BLED, HEMORR2HAGES, ATRIA nor RE-LY) have been developed in a geriatric population. Our study aimed to develop a bleeding risk score adapted to this specific population and this therapeutic class. Multicentre, longitudinal, prospective, observational, pharmacoepidemiologic study conducted in 60 French cardiologic and geriatric centres included consecutive patients aged ≥80 years with AF, treated with rivaroxaban and followed for at least 1 year. All thromboembolic, bleeding and clinical events, including falls, hospitalisations or deaths, were recorded every 3 months for 1 year. A predictive risk score based on the clinical variables most associated with bleeding events was developed from the total sample, randomly divided into a training sample and a validation sample. Among the 839 patients included (mean age = 86 year old, 62% women), there were 78 (9.3%) major haemorrhagic events. Variables associated with bleeding were age, anaemia, low albuminemia, amiodarone use and low creatinine clearance estimated with Cockcroft formula, grouped together as the A4C score. The A4C score better identifies bleeding risk in subjects ≥80 years than the scores already validated in younger populations, as its area under the curve in the training sample and in the validation sample was 0.73 and 0.66, respectively, whereas it was 0.49/0.55 for the HAS-BLED score, 0.53/0.50 for the HEMORR2HAGES score, 0.58/0.61 for the ATRIA score and 0.57/0.54 for the RE-LY score. A threshold of the A4C score ≥ 2 identifies subjects ≥80 years at high risk of bleeding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemorrhageAtrial FibrillationRivaroxabanFactor Xa InhibitorsDecision Support TechniquesAnticoagulantsHumansAged, 80 and overMaleFemaleRisk AssessmentRisk FactorsProspective StudiesAdministration, OralFranceAge FactorsPredictive Value of TestsLongitudinal StudiesTime FactorsReproducibility of ResultsTreatment OutcomeGeriatric AssessmentAged

Stichwörter der Autor:innen

anticoagulantatrial fibrillationbleeding riskolder adultsolder people

Substanzen

RivaroxabanFactor Xa InhibitorsAnticoagulants

Autor:innen und Institutionen

  • APHP, Centre Université Paris Cité - Geriatrics Department, 54-56 rue PASCAL, Paris 75013, France.
  • Université Paris Cité, Inserm UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie, Paris F-75006, France.
  • Medalice, Marly, France.
  • Department of Internal and Geriatric Medicine, Assistance Publique - Hopitaux de Paris - Henri-Mondor Hospital, Paris, Île-de-France, France.
  • University Paris-Est Créteil (UPEC) - CEpiA (Clinical Epidemiology and Ageing), EA 7376- IMRB, Creteil, France.
  • Hôpital Paris Saint-Joseph - Department of Cardiology, Paris, Île-de-France, France.

ORCID-Profile: Matthieu Piccoli, Joël Belmin, Anne Sophie Boureau

Zitieren

APA

Piccoli, M., Pisica-Donose, G., Hacil, A., Orvoën, G., David, J. P., Charbit, J., Roth, R., Antakly, Y., Boulloche, N., Vinsonneau, U., Bouée, S., Krolak-Salmon, P., Fauchier, L., Jouanny, P., Sacco, G., Bellarbre, F., Belmin, J., François, P., Lilamand, M., …, & Vidal, J. S. (2025). A new bleeding risk score specifically developed for direct oral anticoagulants in a geriatric population. Age and Ageing, 54(6). https://doi.org/10.1093/ageing/afaf118

Vancouver

Piccoli M, Pisica-Donose G, Hacil A, Orvoën G, David JP, Charbit J, et al. A new bleeding risk score specifically developed for direct oral anticoagulants in a geriatric population. Age and Ageing. 2025;54(6). doi:10.1093/ageing/afaf118

BibTeX
@article{Piccoli2025,
  author = {Piccoli, Matthieu and Pisica-Donose, George and Hacil, Abdelhakim and Orvoën, Galdric and David, Jean Philippe and Charbit, Judith and Roth, Rafaëlle and Antakly, Yara and Boulloche, Nicolas and Vinsonneau, Ulric and Bouée, Stéphane and Krolak-Salmon, Pierre and Fauchier, Laurent and Jouanny, Pierre and Sacco, Guillaume and Bellarbre, Fabienne and Belmin, Joël and François, Puisieux and Lilamand, Matthieu and Paillaud, Elena and Boureau, Anne Sophie and Hanon, Olivier and Vidal, Jean-Sébastien},
  title = {A new bleeding risk score specifically developed for direct oral anticoagulants in a geriatric population},
  journal = {Age and Ageing},
  year = {2025},
  volume = {54},
  number = {6},
  doi = {10.1093/ageing/afaf118}
}
Kostenlos starten →